Aggravation of pseudomyxoma peritonei recognized 31 months post appendectomy
Abstract
Pseudomyxoma peritonei (PMP) is a rare type of peritoneal secondary tumor. Theincidence of PMP is approximately 1 per million population per year. A 63-year-old Japanese female was referred to our hospital with an acute appenditis. Abdominal computed tomography (CT) scan revealed a peripheral liver ascites. Appendectomy was performed on the same day. A low-grade appendiceal mucinous neoplasm was diagnosed pathologically. She returned to our hospital with an abdominal distention and fullness 31 months post appendectomy. Abdominal CT scan could view an ascites in pelvic cavity. An aggravation of PMP was recognized clinically. PMP is an interesting syndrome with unique clinical and pathologic challenges. Although predictions reveal that, most cases will arise from low-grade appendiceal mucinous lesions, it remains challenging to classify as an entity. Standard treatment is peritoneotomy and hyperthermic intraperitoneal chemotherapy. Then, it needs continued monitoring post appendectomy since the recurrence of PMP is common.
Keywords
References
Sugarbaker PH. Pseudomyxoma peritonei. Cancer Treat Res. 1996; 81: 105-19.
[DOI: 10.1007/978-1-4613-1245-1_10]
Moran BJ, Cecil TD. The etiology, clinical presentation, and management of pseudomyxoma peritonei. Surg Oncol Clin N Am. 2003; 12(3): 585-603.
[PMID: 14567019]; [DOI: 10.1016/s1055-3207(03)00026-7]
Weaver CH. Mucocele of appendix with pseudomucinous degeneration. Am J Surg. 1937; 36:523-6.
[DOI: 10.1016/S0002-9610(37)90763-3]
Werth R. Klinische und anatomische untersuchungen zur lehre von den bauchgeschwülsten und der laparatomie. Arch Für Gynäkol. 1884; 24:100-18.
Mittal R, Chandramohan A, Moran B. Pseudomyxoma peritonei: natural history and treatment. Int J Hyperthermia. 2017; 33: 511-9.
[PMID: 28540829]; [DOI: 10.1080/02656736.2017.1310938]
Castle OL. Cystic dilation of the vermiform appendix. Ann Surg. 1915; 61(5): 582-8.
[PMID: 17863360]; [DOI: 10.1097/00000658-191505000-00007]
Sugarbaker PH. Complete cytoreduction for pseudomyxoma peritonei (Sugarbaker technique). 2011. Guidance and guidelines. NICE [Internet] https://www.nice.org.uk/
guidance/ipg56. Accessed 24 Nov 2011.
Smeenk RM, van Velthuysen ML, Verwaal VJ, Zoetmulder FAN. Appendiceal neoplasms and pseudomyxoma peritonei: a population based study. Eur J Surg Oncol. 2008; 34(2): 196-201.
[PMID: 17524597]; [DOI: 10.1016/j.ejso.2007.04.002]
Esquivel J, Sugarbaker PH. Clinical presentation of the pseudomyxoma peritonei syndrome. Br J Surg. 2000; 87(10): 1414-8.
[PMID: 11044169]; [DOI: 10.1046/j.1365-2168.2000.01553.x]
Behling H. Mucocele of the appendix and jelly-belly. Minn Med. 1967; 50(7):
-12.
[PMID: 6046250]
Ronnett BM, Zahn CM, Kurman RJ, Kass ME, Sugarbaker PH, Shmookler BM. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to “pseudomyxoma peritonei”. Am J Surg Pathol. 1995; 19(12): 1390-408.
[PMID: 7503361]; [DOI: 10.1097/00000478-199512000-00006]
Bradley RF, Stewart JH, Russell GB, Levine EA, Geisinger KR. Pseudomyxoma peritonei of appendiceal origin: a clinicopathologic analysis of 101 patients uniformly treated at a single institution, with literature review. Am J Surg Pathol. 2006; 30(5): 551-9.
[PMID: 16699309]; [DOI: 10.1097/01.pas.0000202039.74837.7d]
Carr NJ, Sobin LH. Adenocarcinoma of the appendix. In: Bosman FT, Carneiro F, Hruban RH, et al., editors. WHO classification of tumors of the digestive system. Lyon: IARC; 2010:12212-5.
Sulkin TVC, O’Neill H, Amin AL, Moran B. CT in pseudomyxoma peritonei: a review of 17 cases. Clin Radiol. 2002; 57(7): 608-13.
[PMID: 12096860]; [DOI: 10.1053/crad.2002.0942]
Jacquet P, Jelinek JS, Chang D, Koslowe P, Sugarbaker PH. Abdominal computed tomographic scan in the selection of patients with mucinous peritoneal carcinomatosis for cytoreductive surgery. J Am Coll Surg. 1995; 181(6): 530-8.
[PMID: 7582228]
Cotton F, Pellet O, Gilly F-N, Granier A, Sournac L, Glehen O. MRI evaluation of bulky tumor masses in the mesentery and bladder involvement in peritoneal carcinomatosis. Eur J Surg Oncol. 2006; 32(10): 1212-6.
[PMID: 16762527]; [DOI: 10.1016/j.ejso.2006.04.013]
Tirumani SH, Fraser-Hill M, Auer R, Shabana W, Walsh C, Lee F, Ryan JG.
Mucinous neoplasms of the appendix: a current comprehensive clinicopathologic and imaging review. Cancer Imaging. 2013; 13(1): 14-25.
[PMID: 23439060]; [DOI: 10.1102/1470-7330.2013.0003]
Low RN, Barone RM, Gurney JM, Muller WD. Mucinous appendiceal neoplasms: preoperative MR staging and classification compared with surgical and histopathologic findings. Am J Roentgenol. 2008; 190(3): 656-65.
[PMID: 18287436]; [DOI: 10.2214/AJR.07.2018]
Wagner PL, Austin F, Sathaiah M, Magge D, Maduekwe U, Ramalingam L, Jones HL, Holtzman MP, Ahrendt SA, Zureikat AH, Pingpank JF, Zeh III HJ, Bartlett DL, Choudry HA. Significance of serum tumor marker levels in peritoneal carcinomatosis of appendiceal origin. Ann Surg Oncol. 2013; 20(2): 506-14.
[PMID: 22941175]; [DOI: 10.1245/s10434-012-2627-5]
Taflampas P, Dayal S, Chandrakumaran K, Mohamed F, Cecil TD, Moran BJ. Pre-operative tumour maker status predicts recurrence and survival after complete cytoreduction and hyperthermic intraperitoneal chemotherapy for appendiceal pseudomyxoma peritonei: analysis of 519 patients. Eur J Surg Oncol. 2014; 40(5): 515-20.
[PMID: 24462284]; [DOI: 10.1016/j.ejso.2013.12.021]
Youssef H, Newman C, Chandrakumaran K, Mohamed F, Cecil TD, Moran BJ. Operative findings, early complications, and long-term survival in 456 patients with pseudomyxoma peritonei syndrome of appendiceal origin. Dis Colon Rectum.
; 54(3): 293-9.
[PMID: 21304299]; [DOI: 10.1007/DCR.0b013e318202f026]
Moran B, Baratti D, Yan TD, Kusamura S, Deraco M. Consensus statement on the loco-regional treatment of appendiceal mucinous neoplasms with peritoneal dissemination (pseudomyxoma peritonei). J Surg Oncol. 2008; 98(4):277-82.
[PMID: 18726894]; [DOI: 10.1002/jso.21054]
Sugarbaker PH, Chang D. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol. 1999; 6(8): 727-31.
[PMID: 10622499]; [DOI: 10.1007/s10434-999-0727-7]
Chua TC, Moran BJ, Sugarbaker PH, Levine EA, Glehen O, GillyDario Baratti FN, Deraco M, Elias D, Sardi A, Liauw W, Yan TD, Barrios P, Portilla AG, de Hingh I H.J.T, Ceelen WP, Pelz JO, Piso P, González-Moreno S, Speeten KVD, Morris DL.
Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol. 2012; 30(20): 2449-56.
[PMID: 22614976]; [DOI: 10.1200/JCO.2011.39.7166]
Sugarbaker PH. Surgical treatment of peritoneal carcinomatosis: 1988 Du Pont lecture. Can J Surg. 1989; 32(3): 164-70.
[PMID: 2713770]
Sugarbaker PH. Peritonectomy procedures. Ann Surg. 1995; 221(1): 29-42.
[PMID: 7826158]; [DOI: 10.1097/00000658-199501000-00004]
Yan TD, Bijelic L, Sugarbaker PH. Critical analysis of treatment failure after complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from appendiceal mucinous neoplasms. Ann Surg Oncol.
; 14(8): 2289-99.
[PMID: 17541772]; [DOI: 10.1245/s10434-007-9462-0]
Omohwo C, Nieroda CA, Studeman KD, Thieme H, Kostuik P, Ross AS, Holter DR, Gushchin V, Merriman B, Sardi A. Complete cytoreduction offers longterm survival in patients with peritoneal carcinomatosis from appendiceal tumors of unfavorable histology. J Am Coll Surg. 2009; 209(3): 308-12.
[PMID: 19717034]; [DOI: 10.1016/j.jamcollsurg.2009.04.019]
Elias D, Gilly F, Quenet F, Bereder JM, Sidéris L, Mansvelt B, Lorimier G, Glehen O. Pseudomyxoma peritonei: a French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy. Eur J Surg Oncol. 2010; 36(5): 456-62.
[PMID: 20227231]; [DOI: 10.1016/j.ejso.2010.01.006]
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution 3.0 License.